Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00785616 · ClinicalTrials.gov registry record · Phase 4

A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence

A Phase 4 study of HIV Infection, sponsored by Montefiore Medical Center.

Completed
Registry status
Phase 4
Development phase
55
Enrollment target
1
Study location

NCT00785616 is a Phase 4 study of HIV Infection that has completed, run by Montefiore Medical Center. The registered enrollment target is 55 participants, below the 242-participant average among 73 other HIV Infection trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00785616, a Phase 4 study of HIV Infection, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This study will enroll completers of a prior 24 week MEMS cap study of Kaletra adherence, conducted in 2005 - 2006, and repeat the MEMS monitoring for an additional 24 weeks in 2008/2009 on the current antiretroviral anchor drug. The goals of the study are to correlate long-term adherence with virologic outcome, and to explore the stability of MEMS cap adherence measurements over time.

Conditions Studied

HIV Infection

Interventions

  • OTHER MEMS cap monitoring

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2008-09
Est. Completion 2009-10
Phase Phase 4

Sponsor

Montefiore Medical Center

345 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00785616

The ClinicalTrials.gov registry entry for NCT00785616 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 73 other HIV Infection trials with a reported enrollment target (77% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infection appearing as the primary indexed condition, and to 1 intervention - of which MEMS cap monitoring is the first listed.

NCT00785616 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00785616 about?

NCT00785616 is a clinical study titled "A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence". This study will enroll completers of a prior 24 week MEMS cap study of Kaletra adherence, conducted in 2005 - 2006, and repeat the MEMS monitoring for an additional 24 weeks in 2008/2009 on the current antiretroviral anchor drug. The goals of the study are to correlate long-term adherence with virol...

What is the current status of trial NCT00785616?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2008-09. Estimated completion is 2009-10.

What conditions does trial NCT00785616 study?

This clinical trial studies the following conditions: HIV Infection.

What interventions are being tested in trial NCT00785616?

The interventions under investigation include: MEMS cap monitoring (OTHER).

Who is sponsoring clinical trial NCT00785616?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00785616 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infection

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.